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Summary: To study the role of peripheral catecholamines in plasma and different issues in 
neurogenic hypertension we measured irectly blood pressure, maximum rate of left ventricular 
pressure rise (dp/dtm~) and heart rate through an aortic catheter 5 weeks after total sino-aortic 
baroreceptor deafferentation in male Sprague-Dawley rats. Blood samples were collected through the 
same catheter to determine plasma catecholamine concentrations. Blood pressure and dp/dtmax were 
significantly higher in neurogenic-hypertensive rats when compared with sham operated rats. Plasma 
noradrenaline concentrations and plasma drenaline concentrations reached significantly higher levels 
in neurogenic-hypertensive rats.In the heart noradrenaline content was lower (when calculated per g 
wet weight) and in the adrenal medulla drenaline content was higher in neurogenic-hypertensive rats,
when compared with sham operated controls. A significant positive correlation was found between dp/ 
dtmax and plasma noradrenaline concentrations. 
It is concluded that sino-aortic baroreceptor deafferentation produces a significant chronic hyperten- 
sion, probably supported by elevated plasma catecholamine concentrations and enhanced synthesis and 
release of adrenaline from adrenal medulla. 
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Introduction 
Genetic and experimental nimal models of hypertension presenting some characteristics 
to those found in human essential hypertension have been developed (8, 24). Central and 
peripheral sympathetic nerves have been recently demonstrated to play a role in these 
models (16, 17, 29, 30). The participation of sympathetic neurons in selected cases of human 
essential hypertension has been postulated as well (11). For this reason, an in-depth study of 
sympathetic activity in adequate animal models could be useful to advance our knowledge of 
the sympathetic factor(s) possibly involved in the human disease. 
One of the well studied animal models of experimental hypertension is that of neurogenic 
hypertension (20). This model is produced by total surgical sino-aortic dcaffcrentation i  
dogs (6), rabbits (9), and rats (20). In the rat, neurogenic hypertension develops immedi- 
ately and persists chronically (2, 5, 12, 20). From the results obtained both the peripheral (2) 
and central (5, 27) sympathetic systems were proposed to be involved in the development of
this model. Alexander et al. (2) reported a correlation between elevated blood pressure and 
increased opamine-13-hydroxylase activity in plasma of rats with neurogenic hypertension. 
In addition to sympathetic nerves, evidence is rapidly accumulating on a role of the adrenal 
medulla in neurogenic as well as in other animal models of hypertension, and in selected 
cases of human essential hypertension (11, 16, 17). 
Plasma dopamine-[3-hydroxylase however, at least in man, may not be a very good index 
of rapid changes in sympathetic nerve activity (26). The determination of changes in plasma 
302 
Dominiak et al., Catecholamines in neurogenic hypertensive rats 21 
levels of noradrenaline both in animals and man offers more useful information (15). In 
addition, the state of the art technology for determination of plasma catecholamines (7, 25) 
allows the simultaneous determination of adrenaline levels and gives an index of 
adrenomedullary activity in so far as production and release of catecholamines are con- 
cerned (19). The study of catecholamine metabolism in important arget organs, such as the 
heart, could provide additional valuable information in hypertension studies. Heart 
catecholamines have been demonstrated to be involved in animal models of experimental 
hypertension (28). 
For the reason outlined above we undertook the study of plasma, adrenal and heart 
catecholamine l vels in conscious, unrestrained rats with chronic neurogenic hypertension 
and their sham-operated controls. We compared these levels with basic haemodynamic 
parameters (systolic and diastolic blood pressure, heart rate, dp/dtmax). Our results suggest 
that peripheral sympathetic nerves and adrenal medulla are involved in the development of 
neurogenic hypertension i  the rat. 
Methods 
Animals 
Male Sprague-Dawley rats (SIV 50) from Dr. Ivanovas, Kisslegg, Germany, weighing about 250g 
before baroreceptor deafferentation were used. Animals were housed individually in plastic cages 
(Makrolon | in an air-conditioned, light-dark-cycled (12h) room with lights on from 6 a.m. to 6 p.m. 
They were given food (Altromin | standard iet) and tap water ad libitum. Animals remained in our 
laboratory for one week prior to use. 
Surgical procedures 
Total sino-aortic deafferentation was performed as described by Krieger (20). Atropine (1.4 mg/kg 
i.p.) was administered and the rats were subsequently anaesthetized with ether. Through a ventral neck 
incision the carotid artery and the vagus were carefully dissected from the sympathetic trunk bilaterally. 
A 1 cm long strip of the sympathetic trunk was resected on both sides. The carotid sinus was separated 
bilaterally from the connective tissue and was stripped of nerve fibers. The carotid sinus was then 
painted with 10 % phenol (dissolved in 95 % ethanol). In addition, the cervical sympathetic trunk and a 
section of superior laryngeal nerves were resected. A sham operation was performed by isolating the 
sympathetic trunk and the carotid sinus on both sides without resection. 
Physiological measurements 
Four and a half weeks after sino-aortic deafferentation, anindwelling catheter (PE-50, Clay Adams, 
Parsippany, N.J., USA) was placed into the thoracic aorta through the right carotid artery, and 
heparine (125 I.U.) injected twice daily. Three days after catheter implantation, blood pressure, 
maximum rate of left ventricular pressure rise (dp/dtmax, paper speed: 100 mm/s) and heart rate were 
recorded in conscious rats for five to ten minutes with a Statham pressure transducer (P 23 dB), five 
minutes after connecting the pressure transducer twice daily (8 a.m., 5 p.m.) over a period of 6 days. 
Blood pressure of rats was measured throughout the experiments in a quiet room, without handling. 
During the entire blood pressure measurement procedures the rats had no sight contact with the person 
carrying out the experiments. 
At the end of the 5th week, immediately after blood pressure measurement, blood samples (0.3--0.5 
ml) were taken from the catheters in conscious rats without handling for determination of the plasma 
catecholamine concentrations. Animals were then killed by decapitation under ether anaesthesia and 
the adrenal glands and hearts were removed and placed immediately in liquid nitrogen. Plasma and 
organs were kept frozen at -70 ~ until they were assayed. 
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Determination of catecholamines 
Plasma catecholamines were assayed radioenzymatically by the method of Peuler and Johnson (25) 
with ion pair extraction according to the method of daPrada nd Ziircher (7), using purified catechol-O- 
methyltransferase. H arts were homogenized with a glass homogenizer (F. Braun) in 5 ml 0.1 n HCIO4 
containing 2.5 % EDTA and 2.5 % Na2S205. Each pair of adrenal glands was homogenized in 500 
0.1 n HC104 containing 2.5 % EDTA and 2.5 % Na2S2Os. After centrifugation the catecholamines in 
the supernatant were determined with high performance liquid chromatography (HPLC, F. Waters) 
and electrochemical detection (ELCD, F. Bioanalytical Systems Inc. USA, West Lafayette) using 
dihydroxybenzylamine as an internal standard (Kissinger et al. 1981). 
Statistical nalysis 
Data were statistically evaluated using Student's unpaired t-test and standard linear regression 
analysis. The results are expressed as mean + SEM (31). 
Results 
Haemodynamic changes 
The mean value of all blood pressure measurements in rats with neurogenic hypertension 
(131/107 + 1.8/1.5 mm Hg, n = 8) was significantly increased (p < 0.001) over that of sham- 
operated normotensive control rats (108/84 + 1.7/1.3 mmHg, n = 7) when measured 
directly over a period of 6 days in the morning and the afternoon during the 5th week after 
sino-aortic baroreceptor deafferentation. 
Also at the end of the 5th week (see Methods) blood pressure (fig. la) and dp/dtmax 
(fig. l b) in rats with neurogenic hypertension were significantly higher than in sham- 
operated rats. However, no significant changes in heart rate between both groups of rats 
could be observed (not depicted). 
Plasma catecholamines 
In rats with neurogenic hypertension circulating plasma noradrenaliue concentrations 
were raised significantly to357 + 44.4 pg/ml and circulating adrenaline concentrations to 278 
+ 43.8 pg/ml when compared with sham-operated rats (192 + 29 pg/ml NA; 107 + 26.4 pg/ 
ml A; fig. 2). There was no difference in circulating dopamine concentrations between both 
groups of rats. 
Heart catecholamines 
The heart weight of neurogenic hypertensive rats (1107 _ 39 mg) was significantly higher 
(p < 0.01) than that of sham-operated rats (911 + 38 mg). In addition, there was also a 
significant difference (p < 0.05) between the heart-body ratio of neurogenic hypertensive 
rats (302 • 10 -5) and control rats (273 • 10-5). The noradrenaline content of the hearts in 
neurogenic hypertensive rats was significantly decreased when compared with sham-oper- 
ated control animals (fig. 3 a). The adrenaline and dopamine contents of hearts between the 
both groups of rats showed no difference. In order to obtain some information about the 
changes in heart weight and observed ifferences in noradrenaline content of the heart we 
have calculated the total noradrenaline concentration of the heart, i.e., noradrenaline 
content per heart. The hearts of neurogenic hypertensive rats have a total noradrenaline 
amount of 881 + 54.2 ng and the hearts of controls 853 + 23.5 ng. The difference was not 
significant. 
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Fig. 1. Blood pressure (la) and maximum rate of left ventricular pressure rise (dp/dt . . . .  1 b) in sham- 
operated normotensive (white columns, n = 7) and neurogenic-hypertensive rats (hatched columns, n = 
6) 5 weeks after total sino-aortic baroreceptor deafferentation. Significance l vels: * = p < 0.05, ** = p 
< 0.01, *** = p < 0.001. 
Adrenal  medulla 
In adrenal glands of rats with sino-aortic deafferentation adrenaline content was signifi- 
cantly increased (p < 0.01; fig. 3b). However,  no changes in dopamine and noradrenaline 
contents between both groups of rats could be observed. The wet weight of adrenal glands 
(55.2 _ 3.7 mg, hypertensive animals and 61.9 - 4.3 mg, sham-operated animals) was 
similar. 
Correlations 
In rats with neurogenic hypertension we observed a positive linear correlation between 
circulating plasma noradrenaline concentrations and dp/dtm~ x (fig. 4). However,  in sham- 
operated rats we did not find a significant correlation (r = 0.214) between these parameters. 
Circulating noradrenaline and dp/dtmax were obtained at the same time from the last day of 
the 5th week, as is mentioned above. 
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Fig. 2. Circulating plasma catecholamine concentrations (noradrenaline = NA and adrenaline = A) in 
sham-operated controls (white columns, n = 7) and neurogenic-hypertensive rats (hatched columns, n
= 6) 5 weeks after total sino-aortic baroreceptor deafferentatinn. Significance levels see fig. 1. 
Discuss ion 
Investigations by Kvetnansky et al. (21) have demonstrated that handling and repeated 
immobilization of rats resulted in enhanced circulating plasma catecholamine concentrations 
as well as increased activity of plasma dopamine-[3-hydroxylase. Th refore it is important to 
measure haemodynamic parameters and collect blood samples in rats without handling in a 
quiet room. In our study we have performed all experiments according to the conditions 
mentioned above. 
Our results confirm that chronic neurogenic hypertension persists in rats also 5 weeks 
after total sino-aortic deafferentation (SAD, Krieger, 1964). Earlier reports described 
elevated blood pressure in this model of hypertension up to 4 weeks after deafferentation (3,
5). We could demonstrate a significant elevation of blood pressure and an increase in dp/ 
dtmax 5 weeks after baroreceptor deafferentation. Also an increase in heart-body ratio as an 
index for heart hypertrophy was observed, as has been reported for genetic hypertensive rats 
(4). We also obtained a positive correlation between plasma noradrenaline concentration 
and dp/dtma~. 
On the other hand noradrenaline content in hearts of SAY) rats was significantly 
diminished when calculated per g wet weight. The decreased noradrenaline content of 
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Fig. 3. Heart catecholamines (3a) and adrenal medullary catecholamines (dopamine = DA, norad- 
renaline = NA and adrenaline = A, 3b) in sham-operated controls (white columns, n = 8) and 
neurogenic-hypertensive rats(hatched columns, n = 6) 5 weeks after total sino-aortic baroreceptor 
deafferentation. Significance l vels see fig. 1. 
neurogenic hypertensive rat hearts is due to the muscular hypertrophy of these hearts 
because the total amount of heart noradrenaline content in both groups was similar. It is 
possible that significantly increased circulating plasma noradrenaline of SAD rats is 
nevertheless the result of an enhanced release by the heart or other sympathetic structures, 
probably elicited by stimulation of presynaptic [32-adrenoceptors through high circulating 
adrenaline concentrations (22, 23). This would imply an enhanced cardiac noradrenaline 
turnover. 
Elevated circulating plasma noradrenaline and adrenaline concentrations, (fig. 2), as well 
as the increased adrenaline content in the adrenal medulla, (fig. 3b) indicate that enhanced 
peripheral sympatho-adrenal activity, probably in addition to increased heart work, contri- 
bute to elevated blood pressure. The results are in agreement with observations of 
Alexander et al. (2) and Chalmers et al. (5), who reported elevated opamine-~-hydroxylase 
activity in plasma and increased sympathetic activity in the spinal cord of chronic hyperten- 
sive rats as well as alterations in catecholamine levels and in phenylethanolamine-n-methyl- 
transferase activity in a few brain nuclei and the pineal gland, time dependent since sino- 
aortic deafferentation was performed (27). 
In contrast to our results, Alexander et al. (3) reported no changes in circulating 
noradrenaline and adrenaline in rats three and six weeks after baroreceptor deafferentation 
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Fig. 4. Correlation between circulating plasma noradrenaline (PNA) and maximum rate of left 
ventricular pressure rise (dp/dtmax) in neurogenic-hypertensive rats.r = 0.91, p < 0.05. 
when compared to controls. However, their basal values for noradrenaline and adrenaline in 
control animals are much too high (approximately 400 pg/ml). This may be due to 
inadaequate sampling of blood specimen (noise, handling etc.). 
Enhanced formation of catecholamines by the adrenal medulla during the development of
hypertension i genetic and experimental (DOCA-salt) hypertensive rats has been reported 
recently (16, 17). In addition, it has been shown that blood pressure was significantly 
reduced after depletion of the catecholamines in the adrenal medulla of rats after adminis- 
tration of a hexahydropyrazinoindol compound (10). 
In this context it is of interest hat chronic administration of adrenaline produces elevated 
blood pressure in rats (22). An increased level of circulating adrenaline has also been 
observed in patients with essential hypertension and especially in young patients with 
essential hypertension (11, 13). 
From our results we conclude that deafferentation f baroreceptors resulted in enhanced 
sympatho-adrenal activity/reactivity, leading to increased cardiac work and possibly vaso- 
constriction by stimulation of cq-adrenoceptors, thereby elevating blood pressure. An 
impaired function of baroreceptors may also significantly contribute to other forms of 
experimental hypertension e.g. Dahl S rats (14) as well as to essential hypertension at the 
early stage in humans (1). 
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